Alnylam Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good morning. Thanks for joining us for our 41st Annual Goldman Sachs Conference here. Before we start, I'm going to make some disclosures. We are required to make certain disclosures in public appearances about Goldman Sachs relationships with companies that we discuss. The disclosures relate to investment banking relationships, compensation received or 1% or more ownership. We are prepared to read aloud disclosures for any issuer upon request. However, these disclosures are available in our most recent reports available to you as clients of the firm on our firm portals. Disclosures and updates to these disclosures are also available by ticker on the firm's public website. In addition, disclosures available to research with respect to companies, if any mentioned herein, are available through your investment representative.
Further information on the subject companies may be obtained from Goldman Sachs. Goldman Sachs may beneficially own 1% or more of the securities. Also the view stated by non-Goldman Sachs personnel do
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
